profit from every $100 of sales.
$0$100
NewGenIvf Group
$0.30+6.15% today
-99.8% in 1 year
1-year low $0.281-year high $133.63
Trading close to its lowest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
You pay $0.05 for every $1 of profit it makes in a year.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What NewGenIvf Group sold, what it kept, and what it did with the cash.
Sales went from $5.94 million in 2022 to $4.73 million in 2025, with $9.88 million of profit last year.
SalesProfit
NewGenIvf Group vs. similar companies
NewGenIvf Group grows the slowest of these 5 and is the cheapest for its profits.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| NewGenIvf Group | 0.0× · Cheap | ||
 HCA Healthcare | 15.6× · Fair price | ||
 Fresenius SE & Co. KGaA | 23.5× · Fair price | ||
 IHH Healthcare Berhad | 33.4× · Expensive | ||
 Rede D'Or São Luiz | 15.9× · Fair price |
AI analysis
An AI analyst reads NewGenIvf Group's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 6 | 5 | 5 | 5 | |
| 2 | 2 | 2 | 1 | |
| 0 | 0 | -1 | -11 | |
| 1 | 0 | 0 | 11 | |
| 0 | 0 | -1 | 10 | |
| 2,714.01 | 770.37 | -1,384.28 | 36.48 | |
| 25.9% | 32.7% | 33.6% | 20.2% | |
| 6.7% | 0.8% | -21.4% | -226.9% | |
| 7.7% | 2.5% | -9.7% | 209.0% |
Balance sheet
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 3 | 4 | 4 | 33 |
| Cash | 0 | 0 | 0 | 1 |
| Total debt | 0 | 0 | 3 | 5 |
| Total liabilities | 3 | 1 | 5 | 7 |
| 1 | 4 | -1 | 27 | |
| 0 | 0 | 0 | 0 | |
| 32.8% | 3.0% | -7.3% | 25.9% | |
| 81.5% | 3.5% | 50.0% | 37.1% |
Cash flow
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 2 | -2 | -8 | -11 | |
| 0 | 0 | 0 | 6 | |
| 2 | -2 | -8 | -17 | |
| Dividends paid | 0 | 0 | 0 | 0 |
| – | – | – | – | |
| – | – | – | – |
Valuation
- 0.0×
- 0.1×
- –
- 0.4×
- 0.1×
- –
- 0.4×
- -3,473.4%
- 2,057.8%
- 0.0%
Profitability
- 20.2%
- -226.9%
- 209.0%
- 351.8%
- 26.6%
- 14.0%
- 32.7%
- 28.0%
- -24.7%
- –
Growth
- −7.4%
- −76.2%
- −100.5%
- –
- +1,072.5%
Financial health
- 0.4×
- 0.18
- 14.9%
- 16.8×
- 3.12
- 2.98
- 0.08
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Top 4%of 958
Top 1%of 601
Bottom 9%of 890
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| Apr 1, 2026 | -2.02 | 46.35 | −104.4% |
| Oct 9, 2025 | 1.52 | – | – |
| Sep 30, 2025 | 147.77 | – | – |
| Dec 31, 2024 | -0.95 | – | – |
| Sep 30, 2024 | -0.39 | – | – |
| Dec 31, 2023 | -18.82 | – | – |
| Sep 30, 2023 | 2.50 | – | – |
| Jun 30, 2023 | 1.68 | – | – |
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
2/7Passes 2 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
55No pass
Benjamin Graham
87Pass
Philip Fisher
31No pass
Peter Lynch
21No pass
Joel Greenblatt
78Pass
Charlie Munger
52No pass
Terry Smith
42No pass
Questions about NewGenIvf Group
Is NewGenIvf Group a good stock to buy?
A strong, very profitable business, and the price looks low. 2 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the NewGenIvf Group AI analysis
What does NewGenIvf Group do?
NewGenIvf Group Limited, an investment holding company, provides an assisted reproductive service that helps couples and individuals for fertility treatments in Thailand, Cambodia, Hong Kong, and Kyrgyzstan. It is in Medical Care Facilities.
Does NewGenIvf Group pay a dividend?
No. NewGenIvf Group does not pay a dividend at the moment.
Is NewGenIvf Group stock halal?
No. NewGenIvf Group does not pass our halal screen: its debt is 1,013% of its market value, at or above the 33% limit. How we check
How has NewGenIvf Group stock done over the past year?
Down 99.8% over the past twelve months, to $0.30. It traded between $0.28 and $133.63 and is 99.8% below its high.
Who are NewGenIvf Group's competitors?
The largest listed companies in the same industry are HCA Healthcare, Fresenius SE & Co. KGaA, IHH Healthcare Berhad and Rede D'Or São Luiz. The peers table on this page compares their profit, growth and price with NewGenIvf Group's.
Prices: daily closes to Nov 11, 2026. Fundamentals: company reports via invest-like data.